Total Funding
34
37
Total FundingPost-IPO Debt raised
Growth Score 34 in past quarter
-1 pts
Heat Score 37 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
257643
Oncology Pharma is engages in research and development of therapeutics for oncology.
- Marcel van Heesewijk: FounderPast Role: GET Holding, Supervisory Board
- George Malesek: Interim CEO
About the Company
Oncology Pharma engages in research and development of therapeutics for oncology and prides itself for having a world-class Advisory Board that keeps the Company in the forefront of developing technologies in cancer research, biotechnology, and healthcare.
